BioDelivery Sciences (BDSI) Misses Q4 EPS by 36c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts BDSI Hot Sheet
Price: $5.59 --0%
Financial Fact:
Net (loss) income: -15.98M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Net (loss) income: -15.98M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
BioDelivery Sciences (NASDAQ: BDSI) reported Q4 EPS of $0.19, $0.36 worse than the analyst estimate of $0.55. Revenue for the quarter came in at $32.2 million versus the consensus estimate of $52.4 million.
For earnings history and earnings-related data on BioDelivery Sciences (BDSI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- Datadog shares drop on weak Q4 revenue outlook
- Stifel Positive on Rapport Therapeutics (RAPP): 'remains on track to share longer-term safety data from the ph2a in 4Q26'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
